pharma-company /Medicinal products /Active ingredients

Rx · PZN 16768074

ZERCEPAC 150 mg powder for preparation of a concentrate for solution for infusion vial

German trade nameZERCEPAC 150 mg Pulver zur Herstellung einer Infusions Lösungskonzentrat Durchstechflasche

Active ingredientTrastuzumab

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €623

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for ZERCEPAC 150 mg powder for preparation of a concentrate for solution for infusion vial.

Review purchasing terms

ZERCEPAC 150 mg powder for preparation of a concentrate for solution for infusion vial contains the active ingredient Trastuzumab. One pack size is recorded (PZN 16768074). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.


ZERCEPAC 150 mg powder for preparation of a concentrate for solution for infusion vial was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.